Is FOLD A Good Stock To Buy Now?
At Insider Monkey, we pore over the filings of nearly 817 top investment firms every quarter, a process we have now completed for the latest reporting period. The data we've gathered as a result gives...
Amicus Therapeutics Inc. (FOLD)
Get Email AlertsSector: Pharmaceutical Preparations
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Perceptive Advisors Joseph Edelman | 25,122,048 | $354,723 | -1% | 5.17% |
| 2. | Redmile Group Jeremy Green | 23,075,807 | $325,830 | -8% | 5.98% |
| 3. | VenBio Select Advisor Kurt Von Emster | 10,850,000 | $153,202 | -2% | 2.17% |
| 4. | Palo Alto Investors William Leland Edwards | 7,867,114 | $111,084 | +8% | 6.09% |
| 5. | D E Shaw D. E. Shaw | 7,344,264 | $103,701 | +5% | 0.1% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $23.17 | 1,500 | Director | 39,967 | 2021-01-04 | Filing | |
| $23.50 | 1,500 | Director | 38,467 | 2020-12-01 | Filing | |
| $18.01 | 1,500 | Director | 36,967 | 2020-11-02 | Filing | |
| $14.28 | 1,500 | Director | 35,467 | 2020-10-01 | Filing | |
| $14.62 | 1,500 | Director | 33,967 | 2020-09-01 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $21.51 | 50,000 | Officer, Director | 859,388 | 2021-01-20 | Filing | |
| $22.24 | 22,000 | Officer, Director | 909,388 | 2021-01-15 | Filing | |
| $22.17 | 7,500 | Officer, Director | 745,429 | 2021-01-04 | Filing | |
| $22.17 | 10,514 | Officer, Director | 306,333 | 2021-01-04 | Filing | |
| $24.09 | 5,000 | Officer | 244,344 | 2020-12-21 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 15,728 | $363,317 | 0% | |
| 2. | 670,818 | $15,489 | 0.29% | |
| 3. | 615,124 | $14,204 | 0.11% | |
| 4. | 9,100 | $210 | 0.19% | |
| 5. | 5,986 | $138 | 0% |
News See All
5 Best Biotech Stocks to Invest In
A clinical-stage biopharmaceutical company Global Blood Therapeutics, Inc. (NASDAQ: GBT) is the long-running investment of a billionaire hedge fund manager. The firm first initiated a stake in Global...
Is Amicus Therapeutics, Inc. (FOLD) Going to Burn These Hedge Funds?
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 823 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F filings...
Did Hedge Funds Make The Right Call On Amicus Therapeutics, Inc. (FOLD)?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and successful...
Amicus Therapeutics, Inc. (FOLD): Hedge Funds Folding Their Hands
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 821 13F...
Hedge Funds Have Never Been This Bullish On Amicus Therapeutics, Inc. (FOLD)
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index...
2019 Review: Most Favored Hedge Fund Stocks vs. Amicus Therapeutics, Inc. (FOLD)
2018's fourth quarter was a rough one for investors and many hedge funds, which were naturally unable to overcome the big dip in the broad market, as the S&P 500 fell by about 4.8% during 2018 and...
Hedge Funds Cashed Out Of Amicus Therapeutics, Inc. (FOLD) Too Early
Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged through the end of November. Among them, Facebook and Microsoft ranked among the top 3 picks and...
Were Hedge Funds Right About Souring On Amicus Therapeutics, Inc. (FOLD)?
Hedge funds are known to underperform the bull markets but that's not because they are bad at investing. Truth be told, most hedge fund managers and other smaller players within this industry are very...
Is Amicus Therapeutics, Inc. (FOLD) A Good Stock To Buy?
Before putting in our own effort and resources into finding a good investment, we can quickly utilize hedge fund expertise to give us a quick glimpse of whether that stock could make for a good addition...
Billionaire Hedge Funds
